Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Arylamine N-acetyltransferases (NATs) are a family of enzymes found in eukaryotes and prokaryotes. While the precise endogenous function of NAT remains unknown for most organisms, recent evidence has shown that the expression of human NAT1 is up-regulated in estrogen receptor positive breast cancer....
Автори: | Westwood, I, Kawamura, A, Russell, A, Sandy, J, Davies, S, Sim, E |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2011
|
Схожі ресурси
Схожі ресурси
-
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
за авторством: Russell, A, та інші
Опубліковано: (2009) -
Structure and mechanism of arylamine N-acetyltransferases.
за авторством: Westwood, I, та інші
Опубліковано: (2006) -
Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
за авторством: Brooke, E, та інші
Опубліковано: (2003) -
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
за авторством: Laurieri, N, та інші
Опубліковано: (2014) -
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
за авторством: Kawamura, A, та інші
Опубліковано: (2005)